(Q33229453)

24 July 2017

title

Intranuclear concentration measurements of doxorubicin in living leucocytes from patients treated for a lympho-proliferative disorder (English)

1 reference

24 July 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

18 October 2022

author name string

H. Morjani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1635383

18 October 2022

B. Pignon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1635383

18 October 2022

J. M. Millot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1635383

18 October 2022

V. Debal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1635383

18 October 2022

D. Lamiable

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1635383

18 October 2022

G. Potron

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1635383

18 October 2022

J. C. Etienne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1635383

18 October 2022

M. Manfait

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1635383

18 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1635383

18 October 2022

publication date

1 June 1992

1 reference

full work available at URL

24 July 2017

https://api.elsevier.com/content/article/PII:014521269290015Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

https://api.elsevier.com/content/article/PII:014521269290015Y?httpAccept=text/plain

18 October 2022

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

18 October 2022

1 reference

24 July 2017

volume

16

1 reference

24 July 2017

issue

6-7

1 reference

24 July 2017

page(s)

647-653

1 reference

Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo

24 July 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Mitochondrial membrane modifications induced by adriamycin-mediated electron transport

18 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

18 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell line.

18 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometry.

18 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Role of the aclacinomycin A--doxorubicin association in reversal of doxorubicin resistance in K562 tumour cells

18 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

High-performance liquid chromatographic bioanalysis of anthracycline cytostatic drugs

18 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Pharmacokinetics of daunorubicin and doxorubicin in plasma and leukemic cells from patients with acute nonlymphoblastic leukemia

18 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Differences in uptake of adriamycin and daunomycin by normal BM cells and acute leukemia cells determined by flow cytometry

18 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients

18 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion

18 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Phase I clinical trial and pharmacokinetic evaluation of 4'-0-tetrahydropyranyladriamycin (THP-adriamycin)

18 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography

18 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Patterns of anthracycline retention modulation in human tumor cells

18 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma

18 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

In vitro chemosensitivity testing in chronic lymphocytic leukaemia patients

18 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0145-2126(92)90015-Y

18 October 2022

Identifiers

1 reference

24 July 2017

1 reference